These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 8494392)
21. pH-mediated potentiation of aminoglycosides kills bacterial persisters and eradicates in vivo biofilms. Lebeaux D; Chauhan A; Létoffé S; Fischer F; de Reuse H; Beloin C; Ghigo JM J Infect Dis; 2014 Nov; 210(9):1357-66. PubMed ID: 24837402 [TBL] [Abstract][Full Text] [Related]
22. Discrepancies between predicted and observed rates of intravenous gentamicin delivery for neonates. Sherwin CM; McCaffrey F; Broadbent RS; Reith DM; Medlicott NJ J Pharm Pharmacol; 2009 Apr; 61(4):465-71. PubMed ID: 19298693 [TBL] [Abstract][Full Text] [Related]
23. Acridine orange as an indicator of bacterial susceptibility to gentamicin. Mason DJ; Lloyd D FEMS Microbiol Lett; 1997 Aug; 153(1):199-204. PubMed ID: 9252587 [TBL] [Abstract][Full Text] [Related]
24. Extended-Interval Dosing of Gentamicin Aiming for a Drug-Free Period in Neonates: A Prospective Cohort Study. van Maarseveen EM; Sprij A; Touw DJ Ther Drug Monit; 2016 Jun; 38(3):402-6. PubMed ID: 26836810 [TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetics of gentamicin at traditional versus high doses: implications for once-daily aminoglycoside dosing. Demczar DJ; Nafziger AN; Bertino JS Antimicrob Agents Chemother; 1997 May; 41(5):1115-9. PubMed ID: 9145878 [TBL] [Abstract][Full Text] [Related]
26. [The kinetics of bacterial killing by fluctuating concentrations of antibiotics]. Guggenbichler JP; Allerberger F; Bonatti H; Semenitz E; Dierich MP Wien Klin Wochenschr; 1989 Mar; 101(7):224-9. PubMed ID: 2652890 [TBL] [Abstract][Full Text] [Related]
27. Parameters of bacterial killing and regrowth kinetics and antimicrobial effect examined in terms of area under the concentration-time curve relationships: action of ciprofloxacin against Escherichia coli in an in vitro dynamic model. Firsov AA; Vostrov SN; Shevchenko AA; Cornaglia G Antimicrob Agents Chemother; 1997 Jun; 41(6):1281-7. PubMed ID: 9174184 [TBL] [Abstract][Full Text] [Related]
28. In vitro evaluation and targeting of E. coli internalized by endothelial cells using albumin microspheres loaded with gentamicin. Haswani DK; Nettey H; D'Souza MJ; Oettinger CW Drug Dev Ind Pharm; 2007 Feb; 33(2):181-90. PubMed ID: 17454050 [TBL] [Abstract][Full Text] [Related]
29. Increased phagocytosis and killing of Escherichia coli treated with subinhibitory concentrations of cefamandole and gentamicin in isolated rat livers. Andreana A; Perna P; Utili R; Dilillo M; Ruggiero G Antimicrob Agents Chemother; 1984 Feb; 25(2):182-6. PubMed ID: 6370126 [TBL] [Abstract][Full Text] [Related]
30. Bacterial killing by use of once daily gentamicin dosage in guinea pigs with Escherichia coli infection. Campbell BG; Bartholow S; Rosin E Am J Vet Res; 1996 Nov; 57(11):1627-30. PubMed ID: 8915442 [TBL] [Abstract][Full Text] [Related]
31. Antibacterial activity of piperacillin and gentamicin using a dynamic system simulating in vivo pharmacokinetics. Blenkharn JI J Chemother; 1989 Jul; 1(4 Suppl):487-9. PubMed ID: 16312497 [No Abstract] [Full Text] [Related]
32. Comparative pharmacodynamics of meropenem using an in-vitro model to simulate once, twice and three times daily dosing in humans. Bowker KE; Holt HA; Lewis RJ; Reeves DS; MacGowan AP J Antimicrob Chemother; 1998 Oct; 42(4):461-7. PubMed ID: 9818744 [TBL] [Abstract][Full Text] [Related]
33. Pharmacodynamics of pulse dosing versus standard dosing: in vitro metronidazole activity against Bacteroides fragilis and Bacteroides thetaiotaomicron. Ibrahim KH; Gunderson BW; Hermsen ED; Hovde LB; Rotschafer JC Antimicrob Agents Chemother; 2004 Nov; 48(11):4195-9. PubMed ID: 15504841 [TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetics of single daily dose gentamicin in children with cancer. Shankar SM; Jew RK; Bickert BM; Cavalieri GE; Bell LM; Lange BJ J Pediatr Hematol Oncol; 1999; 21(4):284-8. PubMed ID: 10445890 [TBL] [Abstract][Full Text] [Related]
35. In vitro model simulating the form of exposure of bacteria to antimicrobial drugs encountered in infection. Al-Asadi MJ; Greenwood D; O'Grady F Antimicrob Agents Chemother; 1979 Jul; 16(1):77-80. PubMed ID: 383014 [TBL] [Abstract][Full Text] [Related]
36. Evaluation of four once-daily aminoglycoside dosing nomograms. Wallace AW; Jones M; Bertino JS Pharmacotherapy; 2002 Sep; 22(9):1077-83. PubMed ID: 12222541 [TBL] [Abstract][Full Text] [Related]
37. Short-course gentamicin in combination with daptomycin or vancomycin against Staphylococcus aureus in an in vitro pharmacodynamic model with simulated endocardial vegetations. Tsuji BT; Rybak MJ Antimicrob Agents Chemother; 2005 Jul; 49(7):2735-45. PubMed ID: 15980344 [TBL] [Abstract][Full Text] [Related]
38. [Pharmacokinetic and therapeutic monitoring of gentamicin serum concentration in neonates]. Kaminska E; Piekarczyk A; Prokopczyk J; Zimak J; Sosnowska K; Taljanski W Med Wieku Rozwoj; 2001; 5(2):141-7. PubMed ID: 11679678 [TBL] [Abstract][Full Text] [Related]
39. Kinetics and bactericidal effect of gentamicin and latamoxef (moxalactam) in experimental Escherichia coli endocarditis. Contrepois A; Vallois JM; Garaud JJ; Pangon B; Mohler J; Meulemans A; Carbon C J Antimicrob Chemother; 1986 Feb; 17(2):227-37. PubMed ID: 3516963 [TBL] [Abstract][Full Text] [Related]
40. Bactericidal Effect of Pterostilbene Alone and in Combination with Gentamicin against Human Pathogenic Bacteria. Lee WX; Basri DF; Ghazali AR Molecules; 2017 Mar; 22(3):. PubMed ID: 28304328 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]